2024, Vol 14, No. 2

Editor-in-Chief

Prof. Khosro Adibkia

Original Research

1. Nafion-coated cadmium pentacyanonitrosylferrate-modified glassy carbon electrode for detection of dopamine in biological samples

Mohammad Johari-Ahar, Jaleh Barar* , Pari Karami, Davoud Asgari, Soodabeh Davaran, Mohammad-Reza Rashidi*

Bioimpacts. 2018;8(4): 263-270. doi: 10.15171/bi.2018.29

PMCID: PMC6209831 PMID: 30397581 Scopus ID: 85056094508

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Original Research

2. Preparation and Characterization of a Novel Smart Polymeric Hydrogel for Drug Delivery of Insulin

Behzad Jafari, Farzaneh Rafie, Soodabeh Davaran*

Bioimpacts. 2011;1(2): 135-143. doi: 10.5681/bi.2011.018

PMCID: PMC3648951 PMID: 23678418 Scopus ID: 84872944287

Article

PDF

XML

Cited By:

Original Article

3. PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy

Mina Yousefnezhad, Soodabeh Davaran* , Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi

Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252

PMCID: PMC10329752 PMID: 37431480 Scopus ID: 85157052599

Article

PDF

Full Text

XML

Cited By:

Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).

Original Article

4. Synthesis and characterization of a magnetic bacterial cellulose-chitosan nanocomposite and evaluation of its applicability for osteogenesis

Nahid Rezazadeh , Effat Alizadeh, Somaieh Soltani, Soodabeh Davaran* , Neda Esfandiari*

Bioimpacts. 2024;. doi: 10.34172/bi.2024.30159

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons